Singapore markets closed

Atossa Therapeutics, Inc. (YAG2.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
0.9460-0.0520 (-5.21%)
As of 08:03AM CEST. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-29,831
-26,960
-20,606
-17,828
-17,240
Depreciation & amortisation
11
8
23
47
52.789
Stock-based compensation
5,647
6,788
5,267
3,019
8,844
Change in working capital
1,290
-599
-1,156
-112
-791.297
Accounts payable
-935
1,248
128
1,295
-60.157
Other working capital
-19,915
-20,787
-16,481
-11,579
-9,136
Other non-cash items
-
-
-
939
-
Net cash provided by operating activities
-19,893
-20,760
-16,472
-11,570
-9,128
Cash flows from investing activities
Investments in property, plant and equipment
-22
-27
-9
-9
-7.625
Purchases of investments
-2,000
-4,700
0
-
-
Net cash used for investing activities
-2,022
-4,727
-9
-9
-7.625
Cash flows from financing activities
Common stock issued
-
0
69,668
33,619
0
Other financing activities
-
-
-573
-14
-
Net cash used provided by (used for) financing activities
-1,475
0
113,304
38,552
11,337
Net change in cash
-23,336
-25,487
96,823
26,973
2,201
Cash at beginning of period
117,477
136,487
39,664
12,691
10,490
Cash at end of period
94,087
111,000
136,487
39,664
12,691
Free cash flow
Operating cash flow
-19,893
-20,760
-16,472
-11,570
-9,128
Capital expenditure
-22
-27
-9
-9
-7.625
Free cash flow
-19,915
-20,787
-16,481
-11,579
-9,136